Because TNF-α and possibly other cytokines contributed to cachexia following i.v. injection of iC9-CD19.ζ-MC-modified T cells, we sought to determine if the selection of CD8+ T cells (or depletion of CD4+ cells) could lessen the toxicity while preserving antitumor activity. This evidence concerns the gene CD4 and Cachexia.